Sutent scores against Steve Jobs-type cancer

Pfizer's Sutent delayed the worsening of the type of pancreatic cancer that afflicted Apple Chief Executive Steve Jobs by more than five months longer than a placebo, according to data from a clinical trial. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.